DFFN - ディフュ―ジョン・ファ―マシュ―ティカルズ (Diffusion Pharmaceuticals Inc.) ディフュ―ジョン・ファ―マシュ―ティカルズ

 DFFNのチャート


 DFFNの企業情報

symbol DFFN
会社名 Diffusion Pharmaceuticals Inc (ディフュ―ジョン・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Diffusion Pharmaceuticals Inc. formerly RestorGenex Corporation is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments including radiation therapy and chemotherapy. The Company''s lead product candidate transcrocetinate sodium also known as trans sodium crocetinate (TSC) is used in various cancer types in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The Company''s Diffusion''s technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate TSC with standard-of-care radiation and chemotherapy regimens thus effecting a better patient survival outcome without the addition of harmful side effects. Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types with an initial focus on primary brain cancer (glioblastoma or GBM) pancreatic cancer and brain metastases.   ディフュ―ジョン・ファ―マシュ―ティカルズは米国のバイオ医薬品企業。臨床段階で、がん腫瘍の治療に使用するトランスクロセチン酸ナトリウム(TSC)の開発に従事する。がん細胞に対する放射線治療や化学療法の効果を上げるためにTSCを使用する。また、TSCはにきびなど皮膚の疾患の治療にも使用される。本社はバ―ジニア州シャ―ロッツビル。   Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen to areas where it is needed most. Diffusion's lead product candidate, TSC, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine's most intractable and difficult-to-treat conditions. In addition to TSC, Diffusion's product candidate DFN-529, a novel, allosteric PI3K/Akt/mTOR Pathway inhibitor, is in early-stage development.
本社所在地 1317 Carlton Avenue Suite 200 Charlottesville VA 22902 USA
代表者氏名
代表者役職名
電話番号 +1 434-220-0718
設立年月日 34669
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 11人
url www.diffusionpharma.com
nasdaq_url https://www.nasdaq.com/symbol/dffn
adr_tso
EBITDA EBITDA(百万ドル) -12.11949
終値(lastsale) 0.409
時価総額(marketcap) 20683948.409
時価総額 時価総額(百万ドル) 19.72308
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 6.78838
当期純利益 当期純利益(百万ドル) -11.09095
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Diffusion Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased from $7M to $14.3M. Higher net loss reflects FV/Uls Adjust on Derivatives for Hedging decrease from $10.5M (income) to $0K Depreciation increase from $12K to $55K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.54 to -$0.33.

 DFFNのテクニカル分析


 DFFNのニュース

   Is Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Expensive At $0.40? Heres How To Know.  2021/12/23 14:30:00 Marketing Sentinel
In last trading session, Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) saw 1.58 million shares changing hands with its beta currently measuring 1.47. Companys recent per share price level of $0.40 trading at $0.04 or 11.60% at ring of the bell on the day assigns it a market valuation of $39.72M. That closing price of DFFNs stock is Is Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Expensive At $0.40? Heres How To Know. Read More »
   Stock Gigantic Turns: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), Nordstrom, Inc. (NYSE:JWN)  2021/12/15 00:01:06 Stock Equity
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) with the stream of -1.85% also noticed, India Nordstrom, Inc. (NYSE:JWN) encountered a rapid change of 3.27% in the last hour of Tuesdays trading session. Diffusion The post Stock Gigantic Turns: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), Nordstrom, Inc. (NYSE:JWN) appeared first on Stocks Equity .
   Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 by DelveInsight  2021/12/14 01:00:00 Benzinga
Los Angeles, USA, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 | DelveInsight There are approximately 150+ key companies developing Glioblastoma therapies. The companies with Glioblastoma drug candidates in the most advanced stage are Kintara Therapeutics, Diffusion Pharmaceuticals, Celgene Corporation, Bio-Thera Solutions. DelveInsight''s " Glioblastoma Pipeline Insight " report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Glioblastoma pipeline landscapes. It comprises Glioblastoma pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Glioblastoma therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Glioblastoma pipeline products. Some of the key takeaways from the Glioblastoma Pipeline Report Major companies such as Celgene Corporation, Myeloid Therapeutics, Genenta Science, Inovio Pharmaceuticals, Apogenix, Oncoceutics, Laminar Pharmaceuticals, Celgene Corporation, Bristol-Myers Squibb, Kintara Therapeutics, Kazia Therapeutics, Oncotelic Therapeutics, AstraZeneca, Genentech, Accendatech, Pfizer, Curtana Pharmaceuticals, Crimson BioPharm, Hope Biosciences, and others are developing potential drug candidates to improve the Glioblastoma treatment scenario.
   Latest Tally Of Analyst Opinions: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), B2Gold Corp. (AMEX:BTG)  2021/12/13 00:34:59 Stock Equity
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) with the stream of -2.53% also noticed, India B2Gold Corp. (AMEX:BTG) encountered a rapid change of -0.27% in the last hour of Fridays trading session. Diffusion The post Latest Tally Of Analyst Opinions: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), B2Gold Corp. (AMEX:BTG) appeared first on Stocks Equity .
   Enthralling stocks: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN -1.88%), The Boeing Company (NYSE:BA -1.64%)  2021/12/10 00:09:30 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enthralling stocks: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN -1.88%), The Boeing Company (NYSE:BA -1.64%) appeared first on Stocks Equity .
   Diffusion Pharmaceuticals (NASDAQ:DFFN) Announces Quarterly Earnings Results  2021/03/18 15:47:07 Daily Political
Diffusion Pharmaceuticals (NASDAQ:DFFN) issued its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.01), Yahoo Finance reports. DFFN stock traded down $0.01 during midday trading on Thursday, hitting $1.07. The company’s stock had a trading volume of 5,142,061 […]
   Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients - Stocks News Feed  2021/02/16 14:18:23 Stocks News Feed
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) announces topline data from Phase 1b trial evaluating trans sodium crocetinate (“TSC”) in hospitalized COVID-19 patients with confirmed hypoxemia, the most common cause of tissue hypoxia (deprived of adequate oxygen supply at the tissue level). On Friday, the external safety monitoring committee met to review safety data from the final 1.5 mg/kg dose cohort.… Read More »Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients
   Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?  2021/02/16 13:31:00 PR Newswire
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GTHX, SBBP, SNGX, PIRS, and DFFN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Thinking about buying stock in Jaguar Health, Diffusion Pharmaceuticals, FuelCell Energy, eMagin Corp, or Fluent Inc?  2021/01/13 14:31:00 PR Newswire
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Insider Buys Diffusion Pharmaceuticals Shares  2020/11/18 11:55:00 Benzinga
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on …
   Diffusion Pharmaceuticals (NASDAQ:DFFN) Announces Quarterly Earnings Results  2021/03/18 15:47:07 Daily Political
Diffusion Pharmaceuticals (NASDAQ:DFFN) issued its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.01), Yahoo Finance reports. DFFN stock traded down $0.01 during midday trading on Thursday, hitting $1.07. The company’s stock had a trading volume of 5,142,061 […]
   Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients - Stocks News Feed  2021/02/16 14:18:23 Stocks News Feed
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) announces topline data from Phase 1b trial evaluating trans sodium crocetinate (“TSC”) in hospitalized COVID-19 patients with confirmed hypoxemia, the most common cause of tissue hypoxia (deprived of adequate oxygen supply at the tissue level). On Friday, the external safety monitoring committee met to review safety data from the final 1.5 mg/kg dose cohort.… Read More »Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients
   Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?  2021/02/16 13:31:00 PR Newswire
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GTHX, SBBP, SNGX, PIRS, and DFFN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Thinking about buying stock in Jaguar Health, Diffusion Pharmaceuticals, FuelCell Energy, eMagin Corp, or Fluent Inc?  2021/01/13 14:31:00 PR Newswire
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Insider Buys Diffusion Pharmaceuticals Shares  2020/11/18 11:55:00 Benzinga
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on …

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ディフュ―ジョン・ファ―マシュ―ティカルズ DFFN Diffusion Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)